SCHMID Group is too early to invest in, given management's very poor track record and a likely guidance miss, which has now happened. @KairosPraxis sees a genuine inflection after the stock fell about 50% this year: the backlog grew from €27m in 2024 to €107m, debt fell to €23m, and the EBITDA margin cut reflects lower-margin Chinese demand. SCHMID may still do well over a longer horizon. x.com